Masimo Corporation Reverses Whistleblowers’ $5.4 Million Reward

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Masimo's Q1 bottom line gets an extra boost after the company manages to reverse an $5.4 million lawsuit decision against a pair of former employees turned whistleblowers. California patient monitoring systems maker Masimo (NSDQ:MASI) posted a big boost to its bottom line after successfully reversing a $5.4 million reward to paid to pair of whistleblowers. A California court last month vacated the award after Masimo won summary judgment to dismiss the lawsuit.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC